跳至主要内容
临床试验/IRCT20200502047277N3
IRCT20200502047277N3已完成2 期

Intracerebral Administration of Allogeneic/Autologous Mesenchymal Stem Cells as HSV-TK Gene Vehicle to Treatment of Glioblastoma: Clinical Trial Phase II

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Karnofsky performance status> 70.
  • Adequate hematological function (an absolute neutrophil count > 1500/µl and platelet count > 125000/mm3).
  • Adequate renal function (creatinine < 1.5 times the normal).
  • Adequate hepatic function (aspartate aminotransferase and bilirubin < 1.5 times the normal).
  • Patient who fill informed consent.

排除标准

  • Significant vascular disease.
  • History of recurrent thromboembolism.
  • Prior history of hypertensive crisis or hypertensive encephalopathy.
  • Gastrointestinal fistula or perforation.
  • History of intraabdominal or intracranial abscess within 6 months.
  • Serious non healing wound, ulcer and bone fracture.

研究者

相似试验